Novo Nordisk A/S (NYSE:NVO) Receives $128.00 Consensus PT from Brokerages
Shares of Novo Nordisk A/S (NYSE:NVO – Get Free Report) have earned an average rating of “Hold” from the eleven analysts that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, five have given a hold recommendation, three have assigned a buy recommendation and one has assigned […]
Shares of Novo Nordisk A/S (NYSE:NVO – Get Free Report) have earned an average rating of “Hold” from the eleven analysts that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, five have given a hold recommendation, three have assigned a buy recommendation and one has assigned […]
